Edmp, Inc. Pfizer Inc Transaction History

Edmp, Inc.

$120 Million
Q3 2024

A detailed history of Edmp, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Edmp, Inc. holds 11,280 shares of PFE stock, worth $301,627. This represents 0.27% of its overall portfolio holdings.

Number of Shares

11,280

Holding current value

$301,627

% of portfolio

0.27%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$27.7 - $31.39 $312,456 - $354,079	11,280 New	11,280 $326,000
Q3 2023 Oct 23, 2023	SELL	$32.09 - $37.51 $96,751 - $113,092	-3,015 Reduced 4.74%	60,556 $2.01 Million
Q2 2023 Jul 24, 2023	BUY	$36.12 - $41.79 $17,771 - $20,560	492 Added 0.78%	63,571 $2.33 Million
Q1 2023 Apr 20, 2023	SELL	$39.39 - $51.28 $61,251 - $79,740	-1,555 Reduced 2.41%	63,079 $2.57 Million
Q4 2022 Feb 06, 2023	SELL	$41.75 - $54.5 $136 Million - $177 Million	-3,247,212 Reduced 98.05%	64,634 $3.31 Million
Q4 2022 Feb 01, 2023	BUY	$41.75 - $54.5 $136 Million - $177 Million	3,245,804 Added 4914.76%	3,311,846 $170 Million
Q3 2022 Oct 20, 2022	SELL	$43.76 - $53.42 $7,176 - $8,760	-164 Reduced 0.25%	66,042 $2.89 Million
Q2 2022 Jul 28, 2022	SELL	$46.53 - $55.17 $24,707 - $29,295	-531 Reduced 0.8%	66,206 $3.47 Million
Q1 2022 Apr 28, 2022	SELL	$45.75 - $56.69 $53,985 - $66,894	-1,180 Reduced 1.74%	66,737 $3.46 Million
Q4 2021 Jan 19, 2022	SELL	$41.32 - $61.25 $126,232 - $187,118	-3,055 Reduced 4.3%	67,917 $4.01 Million
Q3 2021 Oct 20, 2021	SELL	$39.25 - $50.42 $3,807 - $4,890	-97 Reduced 0.14%	70,972 $3.05 Million
Q2 2021 Jul 19, 2021	SELL	$35.91 - $40.68 $9,767 - $11,064	-272 Reduced 0.38%	71,069 $2.78 Million
Q1 2021 Apr 20, 2021	SELL	$33.49 - $37.77 $108,675 - $122,563	-3,245 Reduced 4.35%	71,341 $2.59 Million
Q4 2020 Jan 12, 2021	SELL	$33.47 - $42.56 $46,021 - $58,520	-1,375 Reduced 1.81%	74,586 $2.75 Million
Q3 2020 Oct 20, 2020	SELL	$31.75 - $37.25 $60,039 - $70,439	-1,891 Reduced 2.43%	75,961 $2.79 Million
Q2 2020 Jul 20, 2020	SELL	$30.12 - $36.54 $92,769 - $112,543	-3,080 Reduced 3.81%	77,852 $2.55 Million
Q1 2020 Apr 20, 2020	SELL	$27.03 - $38.62 $61,304 - $87,590	-2,268 Reduced 2.73%	80,932 $2.64 Million
Q4 2019 Jan 21, 2020	SELL	$32.92 - $37.36 $32,097 - $36,426	-975 Reduced 1.16%	83,200 $3.26 Million
Q3 2019 Oct 16, 2019	SELL	$32.49 - $42.13 $82,297 - $106,715	-2,533 Reduced 2.92%	84,175 $3.07 Million
Q2 2019 Jul 25, 2019	SELL	$36.98 - $41.52 $214,299 - $240,608	-5,795 Reduced 6.26%	86,708 $3.76 Million
Q1 2019 Apr 16, 2019	SELL	$37.5 - $41.2 $53,625 - $58,916	-1,430 Reduced 1.52%	92,503 $3.93 Million
Q4 2018 Jan 17, 2019	SELL	$38.47 - $43.86 $72,900 - $83,114	-1,895 Reduced 1.98%	93,933 $4.1 Million
Q3 2018 Oct 22, 2018	SELL	$34.47 - $41.81 $17,062 - $20,695	-495 Reduced 0.51%	95,828 $4.22 Million
Q2 2018 Jul 25, 2018	SELL	$32.98 - $35.16 $63,981 - $68,210	-1,940 Reduced 1.97%	96,323 $3.5 Million
Q1 2018 Apr 11, 2018	SELL	$31.91 - $37.02 $38,451 - $44,609	-1,205 Reduced 1.21%	98,263 $3.49 Million
Q4 2017 Jan 16, 2018	SELL	$33.26 - $35.29 $155,656 - $165,157	-4,680 Reduced 4.49%	99,468 $3.64 Million
Q3 2017 Oct 16, 2017	BUY	$31.0 - $34.15 $3.23 Million - $3.56 Million	104,148	104,148 $3.72 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.77 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.38 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Edmp, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Edmp, Inc. with notifications on news.

Account